Skip to content

OSIRIS THERAPEUTICS, INC.

CIK 0001360886

← back to feed
Revenue (TTM)
$142.82M
+20.5% YoY FY Mar 2019
Net Income (TTM)
−$418K
+320.0% YoY FY Mar 2019
EPS Diluted (TTM)
$0.43
+1,683.3% YoY FY Mar 2019
Gross Margin
66.9%
FY Mar 2019
Operating Margin
2.2%
FY Mar 2019
Net Margin
-0.3%
FY Mar 2019
Free Cash Flow (TTM)
−$10.47M
FY Mar 2019
Cash
$16.37M
FY Mar 2019
Total Debt
—
FY Mar 2019
Shares Outstanding
34.53M sh
FY Mar 2019

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings